Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Report Claims Dendreon Facing FDA Panel
TheStreet.com
Tue, 03/2/10 - 10:56 am
Tags:
Dendreon, FDA, Provenge
AstraZeneca Sees Bearish Move
TheStreet.com
Wed, 02/24/10 - 10:02 am
Tags:
AstraZeneca, Dendreon
The Year For Biotechs
Investopedia
Tue, 02/23/10 - 11:25 am
Tags:
Amgen, Dendreon, XenoPort
Dendreon Redux
Seeking Alpha
Sun, 02/21/10 - 11:15 am
Tags:
Dendreon, Provenge, prostate cancer
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 10:58 am
Tags:
FDA, Cadence Pharmaceuticals, Acorda Therapeutics, Auxilium, Gilead Sciences, Shire, Amylin, Cell Therapeutics, Dendreon, InterMune, Amgen, Human Genome, NicOx, Vivus, Arena Pharmaceuticals, Orexigen
4 Winning Biotechs For Your Portfolio: Senior Analyst
CNBC
Mon, 02/8/10 - 12:30 pm
Tags:
Amgen, Gilead Sciences, Dendreon, Acorda Therapeutics
Is The SEC Probing Trading In Dendreon?
Pharmalot
Mon, 02/8/10 - 11:39 am
Tags:
SEC, Dendreon, insider trading
FDA Derides ‘Conspiracy Theory’ Over Provenge Delay
Pharmalot
Fri, 02/5/10 - 10:28 am
Tags:
Provenge, Dendreon, prostate cancer, FDA
Biotech Events to Watch in 2010: FDA Approvals, Expected Deals and Surprises!
BNET Pharma
Mon, 02/1/10 - 10:11 am
Tags:
biotech, FDA, Cadence Pharmaceuticals, Acetavance, Gilead Sciences, Cayston, velaglucerase, Shire, Exenatide LAR, Amylin, Cephalon, NUVIGIL, Cell Therapeutics, pixantrone, Dendreon, Provenge
Five Drugs To Watch (Assuming FDA Approval)
Pharmalot
Mon, 02/1/10 - 10:07 am
Tags:
FDA, Dendreon, Provenge, Victoza, Novo Nordisk, Qnexa, Vivus, Prolia, Amgen, Bayer, JNJ, Xarelto
Dendreon sees full Provenge capacity by mid-2011
Reuters
Wed, 01/13/10 - 09:24 am
Tags:
Dendreon, prostate cancer, Provenge
Biotech Stock Mailbag: Novelos Therapeutics and more
TheStreet.com
Fri, 01/8/10 - 11:20 am
Tags:
Poniard, Novelos Therapeutics, MannKind, Dendreon, Cell Therapeutics, BioDelivery Sciences, Biocryst
Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:14 am
Tags:
Arena Pharmaceuticals, Vivus, Orexigen, Novo Nordisk, Amylin, Eli Lilly, Biogen Idec, Acorda Therapeutics, Dendreon, MannKind
2010 FDA Decisions to Watch
Motley Fool
Sun, 01/3/10 - 11:39 am
Tags:
FDA, Pfizer, Nektar, MannKind, Afresa, Eli Lilly, Amylin, Dendreon, Vivus, Alkermes, Arena Pharmaceuticals, Orexigen
3 Reasons to Sell Dendreon Today
Motley Fool
Sat, 12/19/09 - 12:31 pm
Tags:
Dendreon
Five Biotech Events to Watch in 2010
TheStreet.com
Wed, 12/16/09 - 11:20 am
Tags:
biotech, Medivation, Elan, Pfizer, Dendreon, Vertex Pharmaceuticals, Amgen, InterMune
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:54 am
Tags:
FDA, Dendreon, Arena Pharmaceuticals, Chelsea Therapeutics, Cephalon, Biodel, Auxilium, Novartis, Novo Nordisk, Shire, Vivus, MannKind, Acorda Therapeutics
Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Yahoo/PR Newswire
Sat, 12/12/09 - 12:07 pm
Tags:
Dendreon
Dendreon's New Stock Offering Takes Advantage of Provenge Decision Uncertainty
BNET Pharma
Thu, 12/10/09 - 10:25 am
Tags:
Provenge, Dendreon, stock offering
Dendreon says FDA will disclose Provenge’s fate by May 1
Bizjournals.com
Sun, 11/22/09 - 01:03 pm
Tags:
Provenge, Dendreon, prostate cancer, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.